Avalon (NASDAQ:AVRX)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Avalon Charts. Click Here for more Avalon Charts.](/p.php?pid=staticchart&s=N%5EAVRX&p=8&t=15)
Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced that it is
scheduled to release financial results for the second quarter of 2008 on
Wednesday, August 13, 2008, at approximately 10:00 am Eastern Time. The
Company will host a conference call later that day at 1:00 pm Eastern
Time to provide a company update and discuss the financial results for
the quarter. Interested investors, analysts, members of the media and
the general public can listen to the call live over the Internet or by
dialing the numbers listed below.
Conference Call details:
Dial-In:
(877) 548-7913 (U.S.)
(719) 325-4932 (International)
Passcode: 3593548
Webcast:
To access the call by live webcast, please visit the Investor
Relations section of our website at http://www.Avalonrx.com.
An archived version of the webcast will be available for seven (7)
days on the Company's website.
About Avalon Pharmaceuticals
Avalon is a biopharmaceutical company focused on the discovery,
development and commercialization of first-in-class cancer therapeutics.
Avalon’s lead product candidate, AVN944, an
IMPDH inhibitor, is in Phase II clinical development. Avalon also has
preclinical programs to develop inhibitors of the Beta-catenin and
Aurora/Centrosome pathways, discovery programs for inhibitors of the
Survivin and Myc pathways and partnerships with Merck,
AstraZeneca/MedImmune, ChemDiv, Medarex, and Novartis. AvalonRx®
is the company’s proprietary platform which is
based on large-scale biomarker identification and monitoring, used to
discover and develop therapeutics for pathways that have historically
been characterized as "undruggable." Avalon is headquartered in
Germantown, MD.